Sperm quality in Hodgkin's disease versus non-Hodgkin's lymphoma

A. Botchan*, R. Hauser, R. Gamzu, L. Yogev, J. B. Lessing, G. Paz, H. Yavetz

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

52 Scopus citations

Abstract

The study was conducted to determine the deleterious effect of lymphoma disease on spermatogenesis and to evaluate the possibility that the disease is mediated primarily by inherent mechanisms in Hodgkin's disease and non-Hodgkin's lymphoma patients. A total of 89 patients with lymphoma disease (Hodgkin's and non-Hodgkin's) were referred for sperm preservation prior to adjuvant treatments. A comparison was made of pre- and post-thaw sperm quality between lymphoma patients and healthy volunteers who applied for sperm donation. This was followed by further assessment of the differences between patients with Hodgkin's disease and non-Hodgkin's lymphoma in terms of sperm variables, clinical parameters and blood hormone concentrations. It was found that patients with lymphoma disease had significantly impaired pre-freeze and post-thaw sperm quality compared with that of healthy volunteers. Patients with non-Hodgkin's lymphoma had spermatozoa of higher quality than patients with Hodgkin's disease. No differences were found in the clinical or hormonal parameters between these two groups. As expected, reduced testicular size and abnormal testicular consistency were correlated with decreased sperm quality. The mere presence of cancer disease has a direct negative effect on spermatogenesis, which is probably not related to incidental side-effects. A variable degree of impairment should be expected with different categories of cancer.

Original languageEnglish
Pages (from-to)73-76
Number of pages4
JournalHuman Reproduction
Volume12
Issue number1
DOIs
StatePublished - Jan 1997

Keywords

  • Hodgkin's lymphoma
  • Non-Hodgkin's lymphoma
  • Sperm cryopreservation
  • Sperm variables
  • Spermatogenesis

Fingerprint

Dive into the research topics of 'Sperm quality in Hodgkin's disease versus non-Hodgkin's lymphoma'. Together they form a unique fingerprint.

Cite this